2020 American Transplant Congress
Safety and Efficacy of Valganciclovir for Cytomegalovirus Prophylaxis in Solid Organ Transplant Patients on Hemodialysis
Houston Methodist Hospital, Houston, TX
*Purpose: Cytomegalovirus (CMV) is the most common viral infection after solid organ transplant (SOT) and is associated with significant morbidity and mortality. Valganciclovir (VGCV) is…2020 American Transplant Congress
Successful Use of Tedizolid for the Treatment of Nocardiosis in Transplant Recipients
*Purpose: Nocardiosis is an opportunistic infection occasionally seen after solid organ (SOT) and hematopoietic stem-cell transplantation. Treatment is challenging due to the limited number of…2020 American Transplant Congress
Bile Microbiology and Antibiotic Susceptibility in Liver Transplant Recipients versus Non-Transplant Population
Surgery, Chung-Ang University Hospital, Seoul, Korea, Republic of
*Purpose: The signs and symptoms of biliary infection in liver transplantation (LT) recipients are frequently subtle because of immunosuppression, thereby delaying its diagnosis and increasing…2020 American Transplant Congress
Pediatric Liver Transplantation for Metabolic Liver Diseases versus Biliary Atresia: Single Center Experience
MedStar Georgetown Transplant Institute, Georgetown University Hospital, Washington, DC
*Purpose: The main indication for LT in children has been biliary atresia (BA). Recent advances in surgical management and the development of new immunosuppressants have…2020 American Transplant Congress
The Effect of Desensitization Therapy on Sex Disparity in Living Kidney Transplantation
*Purpose: Sex- and gender-based disparities which have shown women to have lower access to kidney transplantation have been reported. In living kidney transplantation (LKT), pregnancy-related…2020 American Transplant Congress
Impact of Recipient Obesity on Kidney Transplantation Outcome: A Retrospective Cohort Study with a Matched Comparison
*Purpose: The benefit of renal transplantation in obese patients is changeling. This study was undertaken to determine the effect of recipient obesity on patient and…2020 American Transplant Congress
Epidemiology Cytomegalovirus Infection/Disease in Kidney Transplant Recipients: A Systematic Review of Observational Studies
1Merck & Co., Inc., Kenilworth, NJ, 2Evidera, Inc., Waltham, MA, 3Tufts Medical Center, Boston, MA
*Purpose: Efficacy of several CMV anti-viral strategies has been shown in controlled trials for CMV infection/disease in kidney transplant recipients (KTRs). However, a comprehensive analysis…2020 American Transplant Congress
Efficacy of Single-Strength Trimethoprim-Sulfamethoxazole Thrice Weekly for Pneumocysitis Jirovecii Pneumonia Prophylaxis Post Liver Transplantation
Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA
*Purpose: Current guidelines recommend Pneumocystis jirovecii pneumonia (PJP) prophylaxis for at least 6-12 months after liver transplant (LTx) with preferably Trimethoprim-sulfamethoxazole (TMP-SMX) at a daily…2020 American Transplant Congress
Characteristics of Kidney Transplant Patients Diagnosed with Histoplasmosis
University of Nebraska Medical Center, Omaha, NE
*Purpose: Histoplasmosis is responsible for the greatest number of hospitalizations and deaths due to endemic mycoses in the United States. Although lying near the western…2020 American Transplant Congress
Pharmacist Management after Preemptive Monitoring Conversion as a Component of a Cytomegalovirus Antiviral Stewardship Program at a Large Transplant Center
*Purpose: Cytomegalovirus (CMV) in solid organ transplant (SOT) is associated with negative graft and patient outcomes. Prophylactic agents of choice have substantial cytotoxicity, and patients…
- « Previous Page
- 1
- …
- 417
- 418
- 419
- 420
- 421
- …
- 1683
- Next Page »